Our News - Care 4 Quality

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

September 14, 2022

Rosemont Pharmaceuticals Ltd. has made the MHRA aware that the expiry dates stamped on the base of the bottle are incorrect for 2 batches of Atorvastatin 4mg/ml Oral Suspension and 2 batches of Sildenafil 10mg/ml […]

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

September 9, 2022

With the CQC’s New Single Assessment Framework launching in 2023, using compliance software ensures your service remains Safe and Well-Led under the sizeable regulatory changes. Using a healthcare-specific compliance software is one great way you […]

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

August 22, 2022

Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in some Rosuvastatin products. MDR Number MDR 197-08/21 Company name Accord Healthcare Limited Product description Rosuvastatin 5 […]

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

July 22, 2022

Novo Nordisk Limited would like to notify you of a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. MDR Number MDR […]

Continue Reading

CQC Release New Quality Statements

July 21, 2022

Here at Care 4 Quality., we deliver exceptional support to healthcare providers nationally to ensure they are fully compliant with the CQC, delivering industry-leading registration support, bespoke policies and procedures, and compliance software. The CQC […]

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

July 15, 2022

We are delighted to be delivering this month’s webinar in collaboration with WorkNest: “Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages” This is taking place on Wednesday 20 […]

Continue Reading

Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29

June 16, 2022

Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping bag label. MDR Number MDR 198-05/22 Company name Altan Pharma Limited Product […]

Continue Reading

CQC New Strategy Webinar– 10 Tips to Remain Compliant from a CQC Inspector

June 9, 2022

In our June webinar, former CQC Inspector Victoria Carey shares her top 10 tips on how you can remain compliant with the CQC as they shift towards a new assessment framework and method of inspection. […]

Continue Reading

Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27

June 1, 2022

Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states strength as 15mg. MDR Number MDR 171-05/22 Company […]

Continue Reading

Class 4 Medicines Defect Information: Orifarm UK Ltd, Loprazolam 1mg Tablets, EL (22)A/25

May 26, 2022

Orifarm UK have informed us of an error with the Patient Information Leaflet (PIL) packaged within the packs of certain batches. The product name stated in the heading of the PIL has been spelt incorrectly […]

Continue Reading

Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd, Zovirax I.V. 500 mg, EL (22)A/22 updated

May 23, 2022

GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text. MDR Number […]

Continue Reading

Class 2 Medicines Recall: Quadrant Pharmaceuticals Ltd, Mefenamic Acid 500mg film coated tablets, EL (22)A/23

May 17, 2022

Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the tablet […]

Continue Reading

CQC New Strategy- Proactive Preparation

May 13, 2022

Former CQC Inspector Victoria Carey shares her top tips on how you can prepare for the changes in how the CQC will be assessing your service: “With the Care Quality Commission New Strategy Launch on […]

Continue Reading

Care 4 Quality. Webinar: Being Well-Led- Equality in the Workplace

May 10, 2022

We are excited to be hosting an expert webinar for health and social care providers. Join this session to learn more about the CQC’s regulatory requirements for your organisation’s staff, and how you can achieve […]

Continue Reading

CQC Training Event: New Summer Venues

May 10, 2022

We are excited to announce new nationwide venues for our popular training course – Understanding the CQC Framework and How to Achieve Outstanding. This expert training session, delivered by Former National CQC Training Manager, James McQuillin, will now […]

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

Continue Reading

CQC Release New Quality Statements

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

Continue Reading

Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29

Continue Reading

CQC New Strategy Webinar– 10 Tips to Remain Compliant from a CQC Inspector

Continue Reading

Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27

Continue Reading

Class 4 Medicines Defect Information: Orifarm UK Ltd, Loprazolam 1mg Tablets, EL (22)A/25

Continue Reading

Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd, Zovirax I.V. 500 mg, EL (22)A/22 updated

Continue Reading

Class 2 Medicines Recall: Quadrant Pharmaceuticals Ltd, Mefenamic Acid 500mg film coated tablets, EL (22)A/23

Continue Reading

CQC New Strategy- Proactive Preparation

Continue Reading

Care 4 Quality. Webinar: Being Well-Led- Equality in the Workplace

Continue Reading

CQC Training Event: New Summer Venues

Continue Reading

Request a Callback with Our Specialist Team!

CONTACT US

Care 4 Quality Ltd.

CARE HOME SERVICES & PRICING

TRAINING COURSES

LEGAL